日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4

抗体轻链 CDR-1 处的酪氨酸硫酸化可提高对白细胞介素-4 的结合亲和力和中和效力

Aaron M D'Antona, Julie M Lee, Melvin Zhang, Clarence Friedman, Tao He, Lidia Mosyak, Eric Bennett, Laura Lin, Maddison Silverman, Funi Cometa, Caryl Meade, Tyler Hageman, Eric Sousa, Justin Cohen, Kimberly Marquette, Darren Ferguson, Xiaotian Zhong

Exploring Parametric and Mechanistic Differences between Expi293FTM and ExpiCHO-STM Cells for Transient Antibody Production Optimization

探索 Expi293FTM 和 ExpiCHO-STM 细胞之间的参数和机制差异,以优化瞬时抗体生产

Jing Zhou, Guoying Grace Yan, David Cluckey, Caryl Meade, Margaret Ruth, Rhady Sorm, Amy S Tam, Sean Lim, Constantine Petridis, Laura Lin, Aaron M D'Antona, Xiaotian Zhong

Discovery and optimization of a novel anti-GUCY2c x CD3 bispecific antibody for the treatment of solid tumors

发现和优化用于治疗实体肿瘤的新型抗 GUCY2c x CD3 双特异性抗体

Adam R Root, Gurkan Guntas, Madan Katragadda, James R Apgar, Jatin Narula, Chew Shun Chang, Sara Hanscom, Matthew McKenna, Jason Wade, Caryl Meade, Weijun Ma, Yongjing Guo, Yan Liu, Weili Duan, Claire Hendershot, Amy C King, Yan Zhang, Eric Sousa, Amy Tam, Susan Benard, Han Yang, Kerry Kelleher, Fan

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

开发 PF-06671008,一种具有延长半衰期的高效抗 P-钙粘蛋白/抗 CD3 双特异性 DART 分子,用于治疗癌症

Adam R Root, Wei Cao, Bilian Li, Peter LaPan, Caryl Meade, Jocelyn Sanford, Macy Jin, Cliona O'Sullivan, Emma Cummins, Matthew Lambert, Alfredo D Sheehan, Weijun Ma, Scott Gatto, Kelvin Kerns, Khetemenee Lam, Aaron M D'Antona, Lily Zhu, William A Brady, Susan Benard, Amy King, Tao He, Lisa Racie, Ma